Friday 6 November 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024.

Revenue: +22.9%
EPS: −27.9%
Free cash flow: +141.2%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

21.23 0.01 −0.05%

Follow ACAD

Alert me

Market cap: $3.7B
P/E: 10.0×
Fwd P/E: 33.4×
Dividend yield: —
F-score: 6/9
Altman Z: 7.90
Beneish M: −0.89
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	5	5	5
ROE Full definition →		39.89%	37.32%	35.74%	31.43%
ROA Full definition →		28.42%	27.44%	25.64%	23.18%
ROIC Full definition →		16.07%	12.75%	15.42%	18.60%
Return on Tangible Assets Full definition →		49.34%	46.66%	43.23%	37.95%
Average Days of Receivables Full definition →		50.49	49.45	53.32	54.13
Free Cash Flow per Share Full definition →		0.62	0.67	0.85	0.48
Free Cash Flow Full definition →		104.69	113.59	145.63	81.99
Capital Expenditures Full definition →		(5.14)	(9.90)	(14.69)	(15.55)
Other line items
Cash ROIC Full definition →		5.11%	5.41%	6.43%	3.47%
Accounts Receivable Turnover Full definition →		8.47	8.36	7.96	7.57
Accounts Payable Turnover Full definition →		6.57	6.16	3.12	6.01
Inventory Turnover Full definition →		3.14	3.43	3.45	3.29
Average Days of Payables Full definition →		44.72	47.86	161.09	52.09
Days of Inventory on Hand Full definition →		142.19	123.39	117.01	128.75
Tax Rate Full definition →		1.81	2.26	2.14	1.30
Research and Development Expense of Revenue Full definition →		30.69%	29.89%	29.07%	26.57%
Selling, General and Administrative Expense of Revenue Full definition →		51.23%	54.19%	54.48%	53.74%
Share Based Compensation of Revenue Full definition →		4.87%	5.06%	5.10%	5.18%
Operating CF/Net income Full definition →		0.28	0.33	0.42	0.27
Depreciation/Fixed assets Full definition →		0.84	0.55	0.57	0.62
Capex/Depreciation Full definition →		(0.81)	(1.23)	(1.51)	(1.36)
Revenue per Share Full definition →		6.36	6.42	6.64	6.97
Operating CF per Share Full definition →		0.65	0.72	0.93	0.57
Capex per Share Full definition →		(0.03)	(0.06)	(0.09)	(0.09)
Capex to Sales Full definition →		0.00	0.01	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly